Peptide questions deserve
specific answers.
Peptides are a broad category. A meaningful discussion starts with the exact compound, intended use, available evidence, and its regulatory status.
Care starts with a conversation.
Sermorelin consultation
Discuss the proposed indication, source, evidence, and risks before considering any regimen.
BPC-157 education
Review available human evidence and FDA safety concerns. A marketing claim about tissue repair does not establish clinical effectiveness.
CJC-1295 / ipamorelin education
Ask about the specific combination, safety concerns, and the limits of evidence for wellness or performance uses.
Medication & wellness review
Consider established options for your symptoms and goals before assuming a peptide is the right choice.
Know what to expect.
01 / Evaluation
We discuss your goals, medical history, medications, and previous treatments before recommending an approach.
02 / A clear plan
Review the specific treatment, alternatives, costs, possible side effects, and recovery before making a decision.
03 / Follow-up
Your plan includes preparation and aftercare instructions, plus a chance to review your response and next steps.
Compounded products are not FDA-approved. The FDA identifies safety concerns for several peptide ingredients, including BPC-157, CJC-1295, and ipamorelin. This page provides consultation topics rather than a guarantee that a particular compound can be prescribed or is appropriate for you.
Patient education: FDA information on compounding safety concerns ↗